The study of the lectin level in healthy population,vulvovaginal candidiasis (VVC) and recurrent vulvovaginal candidiasis (RVVC) groups

Abstract

Abstract: Objective To value the levels of mannose lectin in healthy population, vulvovaginal candidiasis (VVC) and recurrent vulvovaginal candidiasis (RVVC) groups.Method All the VVC and RVVC cases were given standardized treatment. Compared with healthy population, the MBL levels before and after treatment were observed in these two groups.Results The MBL levels of vvc group,RVVC group,healthy group were arranged from high to low numerically. But there was no significant difference among groups or within every group before and after treatment(P>0.05). There were 14% (5/43) cases of recurrence in VVC group and 48% (13/30) cases of recurrence in RVVC group,respectively. There was no significant differecne of recurrence between VVC and RVVC groups(P>0.05).Conclusion The level of MBL is higher numerically in VVC group than the level in RVVC group. The recurrence in both groups is consistet with the previously literature. The VVC patients with MBL level higer than 0.8 ng/mL seems to have lower risk of suffering RVVC.

Key words: vulvovaginal candidiasis, mannan binding lectin, recurrence

CLC Number:

R756.2

LIU Ge, WANG Wei-hua, SUN Jing, MA Xue-feng, CHEN ai-qun. The study of the lectin level in healthy population,vulvovaginal candidiasis (VVC) and recurrent vulvovaginal candidiasis (RVVC) groups[J]. Chinese Journal of Mycology, 2013, 8(3): 160-162,168.

References

[1] Walker PP, ReynoldsMT, Ashbee HR, et al. Vaginal yeasts in the era of"over the counter"antifungals[J]. Sex Transm Infect, 2000,76 (6): 437-438.
[2] Fidel PL, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis[J]. Clin Microbiol Rev, 1996, 9 (3): 335-348.
[3] 刘朝晖,廖秦平. 外阴阴道念珠菌病高发区与低发区患者的流行病学研究[J]. 中国全科医学, 2006, 9 (8): 630-631.
[4] Fidel PL J r. Immunity in vaginal candidiasis[J]. Curr Op in Infect Dis, 2005, 18 (2): 107-111.
[5] Faro S. Vaginitis: Differential diagnosis and Management[M]. Boca Raton: Parthenon Pub Group, 2004: 45-65.
[6] Recurrent vulvovaginalcandidiasis, RVVC Sobel JD. Vulvovaginal candidosis[J]. Lancet, 2007, 369 (9577):1961-1971.
[7] 中华妇产科学分会感染性疾病协作组.外阴阴道念珠菌病诊治规范(草案) [J].中华妇产科杂志,2004,39(6):430.
[8] 乐杰.妇产科学[M].第7版.北京:人民卫生出版社,1994:239.
[9] Takanhashi K,Ezekowits RA.The Role of the Mannose binding Lectin in Innate Immunit[J].Clin Infect Dis,2005,41(7):440-444.
[10] Ikeda K,Sannoh T,Kawasaki N et al. Serum lectin with known structure activates complement through the classical pathway[J]. J Biol Chem, 1987,262(16):7451-7454.
[11] Tabona P,Mellor A,Summerfield J A.Mannose binding protein is involved in first-line host defence:evidence from transgenic mice[J]. Immunolgy,1995,85 (1):153.
[12] Netho,Jackd L,Doddsaew, et al. Mannose2binding lec tin binds to a range of clinically relevant microorganisms and p romotes comp lement diposition [J]. Infect Immune, 2000, 68(2):688-693.
[13] Liu F, Liao Q, Liu Z. Mannose-binding lectin and vulvovaginalcandidiasis[J]. Int J Gynaecol Obstet, 2006, 92 (1): 43-47.
[14] Giraldo PC, Babula O, Gon alvesAK, et al. Mannose2bindinglectin gene polymorphism, ulvovaginal candidiasis, and bacterial vaginosis[J]. Obstet Gynecol, 2007, 109 (5): 1123-1128.
[15] Heni E, Thiel S, Mrdh PA. Mannan-binding lectin in women with a history of recurrent vulvovaginal candidiasis [J]. Eur J Obstet Gynecol Reprod Biol, 2010, 148(2): 163-165.
[16] Milanese M, Segat L, De Seta F, et al. MBL2 genetic screening in patients with recurrent vaginal infections [J].Am J Reprod Immunol, 2008, 59(2): 146-151.H